NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 338 filers reported holding NEOGENOMICS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,453,385 | -27.4% | 687,267 | -5.2% | 0.01% | -25.0% |
| Q2 2023 | $11,651,618 | -14.4% | 725,054 | -7.3% | 0.01% | -20.0% |
| Q1 2023 | $13,618,815 | +86.3% | 782,241 | -1.1% | 0.01% | +66.7% |
| Q4 2022 | $7,311,779 | +7.7% | 791,318 | +0.3% | 0.01% | +20.0% |
| Q3 2022 | $6,792,000 | +6.4% | 788,854 | +0.7% | 0.01% | 0.0% |
| Q2 2022 | $6,384,000 | -38.0% | 783,290 | -7.5% | 0.01% | -16.7% |
| Q1 2022 | $10,292,000 | -64.6% | 847,050 | -0.7% | 0.01% | -64.7% |
| Q4 2021 | $29,113,000 | -29.9% | 853,262 | -0.9% | 0.02% | -37.0% |
| Q3 2021 | $41,528,000 | +10.3% | 860,871 | +3.3% | 0.03% | +12.5% |
| Q2 2021 | $37,652,000 | -8.3% | 833,565 | -2.1% | 0.02% | -17.2% |
| Q1 2021 | $41,081,000 | -6.2% | 851,760 | +4.7% | 0.03% | -9.4% |
| Q4 2020 | $43,796,000 | +47.3% | 813,451 | +0.9% | 0.03% | +28.0% |
| Q3 2020 | $29,735,000 | +14.7% | 806,037 | -3.7% | 0.02% | +8.7% |
| Q2 2020 | $25,935,000 | +17.2% | 837,169 | +4.5% | 0.02% | -4.2% |
| Q1 2020 | $22,125,000 | -9.3% | 801,325 | -3.9% | 0.02% | +20.0% |
| Q4 2019 | $24,402,000 | +43.7% | 834,260 | -6.0% | 0.02% | +33.3% |
| Q3 2019 | $16,977,000 | -12.3% | 887,912 | +0.7% | 0.02% | -11.8% |
| Q2 2019 | $19,354,000 | +16.2% | 882,114 | +8.4% | 0.02% | +6.2% |
| Q1 2019 | $16,652,000 | +2404.1% | 813,871 | +1443.4% | 0.02% | +1500.0% |
| Q4 2018 | $665,000 | +267.4% | 52,734 | +347.0% | 0.00% | – |
| Q3 2018 | $181,000 | +75.7% | 11,798 | +2.5% | 0.00% | – |
| Q2 2017 | $103,000 | -41.1% | 11,509 | -48.1% | 0.00% | – |
| Q1 2017 | $175,000 | -5.9% | 22,164 | +2.5% | 0.00% | – |
| Q4 2016 | $186,000 | +118.8% | 21,619 | +109.0% | 0.00% | – |
| Q3 2016 | $85,000 | +2.4% | 10,343 | 0.0% | 0.00% | – |
| Q2 2016 | $83,000 | +18.6% | 10,343 | 0.0% | 0.00% | – |
| Q1 2016 | $70,000 | -12.5% | 10,343 | -30.0% | 0.00% | – |
| Q2 2015 | $80,000 | +42.9% | 14,785 | -8.7% | 0.00% | – |
| Q1 2014 | $56,000 | -5.1% | 16,194 | -0.9% | 0.00% | – |
| Q4 2013 | $59,000 | +20.4% | 16,348 | 0.0% | 0.00% | – |
| Q3 2013 | $49,000 | – | 16,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |